↓ Skip to main content

Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy

Overview of attention for article published in Cardiovascular Diabetology, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
twitter
3 X users

Citations

dimensions_citation
126 Dimensions

Readers on

mendeley
134 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
Published in
Cardiovascular Diabetology, January 2020
DOI 10.1186/s12933-019-0980-4
Pubmed ID
Authors

M. Arow, M. Waldman, D. Yadin, V. Nudelman, A. Shainberg, N. G. Abraham, D. Freimark, R. Kornowski, D. Aravot, E. Hochhauser, M. Arad

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 134 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 134 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 10%
Researcher 12 9%
Student > Master 11 8%
Student > Bachelor 9 7%
Student > Doctoral Student 8 6%
Other 16 12%
Unknown 64 48%
Readers by discipline Count As %
Medicine and Dentistry 29 22%
Biochemistry, Genetics and Molecular Biology 10 7%
Pharmacology, Toxicology and Pharmaceutical Science 9 7%
Agricultural and Biological Sciences 8 6%
Engineering 3 2%
Other 11 8%
Unknown 64 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 January 2020.
All research outputs
#2,939,348
of 23,186,937 outputs
Outputs from Cardiovascular Diabetology
#197
of 1,414 outputs
Outputs of similar age
#71,885
of 456,275 outputs
Outputs of similar age from Cardiovascular Diabetology
#5
of 26 outputs
Altmetric has tracked 23,186,937 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,414 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 456,275 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.